Kintiga Information

Kintiga helps global pharma and biotech teams make the European access decisions that matter most. We partner with clients from early strategy and evidence generation through launch, HTA and reimbursement, helping them navigate an increasingly complex and interconnected European access environment. By combining deep expertise across market access, HEOR, medical affairs, regulatory affairs, stakeholder engagement and evidence generation, we help clients make critical decisions earlier, connect strategy across markets and build plans that stand up to scrutiny. Our connected European team brings together expertise from Europe's two methodological archetypes (added benefit and cost-effectiveness reasoning) and is positioned at the centre of Europe's access ecosystem, combining local understanding with a broader European perspective. We translate policy and system change into strategic action, helping clients anticipate challenges, strengthen evidence strategies and make confident access decisions across the asset lifecycle. As an independent European specialist, we stay close to the asset and the client team, providing strategic continuity, constructive challenge and expert support as priorities evolve. Through our AI-Accelerated. Expert Accountable approach, we combine purpose-built digital capabilities with deep human expertise to deliver faster insight, stronger evidence and accountable decision support. Access decisions, built for a changing Europe. Email: enquiries@kintiga.com